CN Patent

CN110403904A — 卡贝缩宫素注射液及其应用

Assigned to Xiang Yu Pharmaceutical Ltd Co · Expires 2019-11-05 · 7y expired

What this patent protects

本发明涉及卡贝缩宫素注射液及其应用，属于氨基酸合成技术领域，公开了一种注射液，其包括半衰期延长的卡贝缩宫素和药物学上可接受的辅料。本发明产品半衰期延长，稳定性提升，可用于治疗或预防子宫张力缺失，和/或用于治疗或预防经阴道分娩后的过度出血。

USPTO Abstract

本发明涉及卡贝缩宫素注射液及其应用，属于氨基酸合成技术领域，公开了一种注射液，其包括半衰期延长的卡贝缩宫素和药物学上可接受的辅料。本发明产品半衰期延长，稳定性提升，可用于治疗或预防子宫张力缺失，和/或用于治疗或预防经阴道分娩后的过度出血。

Drugs covered by this patent

Patent Metadata

Patent number
CN110403904A
Jurisdiction
CN
Classification
—
Expires
2019-11-05
Drug substance claim
No
Drug product claim
No
Assignee
Xiang Yu Pharmaceutical Ltd Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.